Yahoo! Finance Search - Finance Home - Yahoo! - Help

Sunday, March 1 2015 2:28pm ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Major News
Latest News
Friday, Feb 27, 2015
·Is the Best Plan for Pot Investing 'Wait-and-see?'
at Investopedia - Fri 5:20 pm ET
·Interested In Pharmaceutical Stocks? Try Novartis (ADR)
at Investopedia - Fri 4:15 pm ET
·U.S. Food and Drug Administration Accepts Biologics Licensing Application for Opdivo (nivolumab) for the Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Business Wire - Fri Feb 27
·Who Might Buy Puma Biotechnology?
at - Fri Feb 27
·Gadfly Pharma Investor Shkreli Starts Anew After Ousting From Retrophin
at - Fri Feb 27
·Afrezza's Initial Sales Create Buying Opportunity
at - Fri Feb 27
·Why should you invest in healthcare ETFs?
- Fri Feb 27
·Novartis lung cancer drug gets EU recommendation
Reuters - Fri Feb 27
·Innovus Pharmaceuticals to Sponsor the Living Menopause Positively Event by Oakdale Obstetrics & Gynecology on March 7, 2015 with its Zestra(R) Product
- Fri Feb 27
·Decision on Ebola mass vaccination in August at earliest - WHO
Reuters - Fri Feb 27
·Decision on widespread Ebola vaccination in August at earliest - WHO
Reuters - Fri Feb 27
Thursday, Feb 26, 2015
·Raptor Pharmaceutical reports 4Q loss
AP - Thu Feb 26
·Sanofi's diabetes drug Toujeo gets U.S. approval, label disappoints
Reuters - Thu Feb 26
·Rockwell Medical reports 4Q loss
AP - Thu Feb 26
·AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting
PR Newswire - Thu Feb 26
·Tetraphase to Host Conference Call Discussing Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights
GlobeNewswire - Thu Feb 26
·Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Corporate Update
GlobeNewswire - Thu Feb 26
·Rockwell Medical Reports Fourth Quarter 2014 Results
GlobeNewswire - Thu Feb 26
·Merck’s 9-Valent HPV Vaccine, GARDASIL®9, Recommended by CDC’s Advisory Committee on Immunization Practices for Females Aged 9-26 and Males Aged 9-21
Business Wire - Thu Feb 26
·Bristol hep C drug helps cure 97 pct of HIV coinfected patients-study
Reuters - Thu Feb 26
More Latest News...
Sponsor Results
$5,730 College Grant
Get Degree 100% Online University or College Grant if Qualify. Act Now.
Actuary Jobs D.W. Simpson
Worldwide actuarial recruitment company. See our salary surveys, too.
This Just In
New Industry Insights Regarding Industry News.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?